Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001562180-23-000403
Filing Date
2023-01-12
Accepted
2023-01-12 20:03:08
Documents
1
Period of Report
2023-01-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 7510
  Complete submission text file 0001562180-23-000403.txt   9184
Mailing Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60
Business Address SPACES SOUTH DOCKLANDS, BLOCK C 77 SIR JOHN ROGERSON'S QUAY DUBLIN 2 L2 D02 VK60 353 1 6699 020
AMARIN CORP PLC\UK (Issuer) CIK: 0000897448 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O NOVELION THERAPEUTICS INC. 1800-510 WEST GEORGIA STREET VANCOUVER A1 V6B OM3
Business Address
Stewart Murray (Reporting) CIK: 0001723450 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-21392 | Film No.: 23526943